home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Biosimilars & Biobetters Congress 2013

 
  February 04, 2013  
     
 
Oxford Global Conferences, London
25th&26th March 2013


The Event

In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 25 speakers will present a full conference programme covering the topics outlined below:

Day 1  – Market Opportunities and Commercial Challenges

  • Substitution & interchangability
  • Commercialising biosimilars
  • Outsourcing and partnering
  • Opportunities in emerging markets
  • Market access initiatives
  • Technological advances
  • Global regulatory strategy

Day 2 – Developing Biosimilars and Biobetters

  • Demonstrating biosimilarity
  • Identifying successful biobetters
  • Characterisation of complex proteins
  • Increasing potency
  • Developing mAbs
  • PK/PD testing
 
 
Organized by: Oxford Global Conferences
Invited Speakers:
  • Shein-Chung Chow
    Professor of Biostatistics and Bioinformatics, Duke University School of Medicine
  • Paul Cornes
    Consultant, University Hospitals Bristol
  • Lolke De Haan
    Director of Toxicology, MedImmune
  • Theodor Dingermann
    Director of the Institute of Pharmaceutical Biology, Goethe University
  • Ashish Dugar
    Head, Medicines Development Group, Pfizer Biosimilars
  • (Stream Chair) Dan Hartley,
    Senior Vice President, Associate General Counsel, Shire (UK)
  • Thierry Hulot
    Vice President, Head of Biosimilars Unit, Merck Serono
  • Frank Landolt
    Vice President, Intellectual Property and Legal, Ablynx
  • Bernd Liedert
    Director, Head of Immunopharmacology, Merck Serono
  • Lioba Lobmayr
    Quality Assurance Manager, External Supply Operations, Novartis
  • Dragan Majetic
    Vice-President Therapeutic Area Neurology and Interim VP - Neurology Business Unit USA, Merz
  • Alexander Mencik
    Associate General Counsel, Amgen
  • Sophie Opdyke
    Vice President, Commercial Development Biosimilars, Pfizer
  • Mohamed Oubihi
    Associate Director, Regulatory Affairs, Abbott
  • Alexandre Richard
    Head of Competitive Intelligence, Sanofi
  • Paul Rösch
    Professor, Biophysical Chemistry, University of Bayreuth
  • Paul Tredwell
    Head of Biopharmaceuticals, Sandoz
  • Gary Walsh
    Professor of Industrial Chemistry, University of Limerick
  • Robert E. Zoubek
    Director Scientific Affairs & Client Relationship, Formycon
 
Deadline for Abstracts: NA
 
Registration: For more information and to register: http://www.biosimilars-congress.com/download-agenda/
E-mail: d.meredith@oxfordglobal.co.uk
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.